AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
EMPAGLIFLOZIN 10 Mg ; Linagliptin 5 Mg ;
17 registrations across 1 African market— 17 active
Markets with EMPAGLIFLOZIN 10 Mg ; Linagliptin 5 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Glyxambi 10/5 mg Film Coated Tablets | 🇪🇬Egypt | Boehringer Ingelheim | active | — |
| Diacurimap plus 10/5 mg Film Coated Tablets | 🇪🇬Egypt | Apex pharma | active | — |
| Empalidiab 10/5 mg Film Coated Tablets | 🇪🇬Egypt | Liptis for Pharmaceuticals and Medical Products | active | — |
| Empaglipt 10/5 mg Film Coated Tablets | 🇪🇬Egypt | Western Pharmaceuticals Industries | active | — |
| Empalidiab 10/5 mg Film Coated Tablets | 🇪🇬Egypt | Liptis for Pharmaceuticals and Medical Products | active | — |
| Flozigliptin 10/5 mg Film Coated Tablets | 🇪🇬Egypt | AVERROES PHARMA for pharmaceutical industries | active | — |
| Empappegoal Duo 10/5 mg Film Coated Tablets | 🇪🇬Egypt | Zeta Biotech | active | — |
| Empappegoal Duo 10/5 mg Film Coated Tablets | 🇪🇬Egypt | Zeta Biotech | active | — |
| Empaglipt 10/5 mg Film Coated Tablets | 🇪🇬Egypt | Western Pharmaceuticals Industries | active | — |
| Flozigliptin 10/5 mg Film Coated Tablets | 🇪🇬Egypt | AVERROES PHARMA for pharmaceutical industries | active | — |
| Diacurimap plus 10/5 mg Film Coated Tablets | 🇪🇬Egypt | Apex pharma | active | — |
| Empacoza Plus 10/5 mg Film Coated Tablets | 🇪🇬Egypt | pharmaglob | active | — |
| Empacoza Plus 10/5 mg Film Coated Tablets | 🇪🇬Egypt | pharmaglob | active | — |
| Mellitofix Comb 5/10 mg Film Coated Tablets | 🇪🇬Egypt | Eva pharma for Pharmaceuticals and Medical Appliances - Eva Pharma | active | — |
| Glyxambi 10/5 mg Film Coated Tablets | 🇪🇬Egypt | Boehringer Ingelheim | active | — |
| Lingalabs 10/5 mg Film Coated Tablets | 🇪🇬Egypt | P and C Labs - Pellets and CR Products | active | — |
| Empacyrl 10/5 mg Film Coated Tablets | 🇪🇬Egypt | Marcyrl pharmaceutical industries - MPI | active | — |
EMPAGLIFLOZIN 10 Mg ; Linagliptin 5 Mg ; in Africa — Regulatory Overview
EMPAGLIFLOZIN 10 Mg ; Linagliptin 5 Mg ; is registered across 1 African markets with 17 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 17 registrations, 17 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.